ESTRACE Side Effects

7010894-1 | Alopecia, Burning Sensation, Fungal Infection, Injury, Lacrimation Increased, Muscle Atrophy, Muscular Weakness, Pruritus
on Sep 23, 2010 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with vaginal haemorrhage, vaginal perforation, bacterial infection (What is bacterial infection?), fungal infection (What is fungal infection?) and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, burning sensation, fungal infection (What is fungal infection?), injury, lacrimation increased, muscle atrophy, muscular weakness, pruritus. Estrace dosage: Small Ammount Every Night Insert Into Vag. During the same period patient was treated with TOPICORT (Small Ammount Outside Vag Every Night) (View Topicort Review and Topicort Label ).

7002437-3 | Myocardial Infarction
Patient was taking Estrace (View Usage). Patient had the following side effects: myocardial infarction on Sep 17, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 122.4 lb, was diagnosed with menopause (What is menopause?) and. Estrace dosage: 1/4 Applicator Full Every Night Vaginally.

6992740-5 | Mastectomy, Menopause
Adverse event was reported on Sep 16, 2010 by a Female patient taking Estrace (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 133.0 lb, After Estrace was administered, patient had the following side effects: mastectomy (What is mastectomy?), menopause (What is menopause?). Patient was hospitalized.

6959486-0 | Heart Rate Irregular, Oedema Peripheral, Supraventricular Tachycardia
on Aug 13, 2010 Female patient from UNITED STATES , 74 years of age, weighting 145.1 lb, was diagnosed with vaginal infection and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: heart rate irregular, oedema peripheral, supraventricular tachycardia. Estrace dosage: Single Dose, Vaginal. During the same period patient was treated with TOPRIL (RAMIPRIL) (View Topril (ramipril) Review and Topril (ramipril) Label ), NORVASC (View Norvasc Review and Norvasc Label ), PRINIVIL (LISINOPRIL DIHYDRATE) (View Prinivil (lisinopril Dihydrate) Review and Prinivil (lisinopril Dihydrate) Label ).


6920238-9 | Atrioventricular Block, Cystitis, Head Injury, Loss Of Consciousness, Vaginal Haemorrhage, Vaginitis Bacterial, Vulvovaginal Mycotic Infection
on Jul 27, 2010 Female patient from UNITED STATES , 83 years of age, weighting 125.9 lb, was diagnosed with vaginal haemorrhage, vaginitis bacterial, vulvovaginal pain and was treated with Estrace (View Usage). Patient had the following side effects: atrioventricular block, cystitis, head injury, loss of consciousness, vaginal haemorrhage, vaginitis bacterial, vulvovaginal mycotic infection. Estrace dosage: 1gram, Monday, Wednesday, Friday, Vaginal. During the same period patient was treated with CALCIUM (CALCIUM GLUBIONATE) (View Calcium (calcium Glubionate) Review and Calcium (calcium Glubionate) Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), COUMADIN (COUMARIN) (View Coumadin (coumarin) Review and Coumadin (coumarin) Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6914458-7 | Fatigue, Headache, Vaginal Infection
Patient was taking Estrace (View Usage). After Estrace was administered, patient had the following side effects: fatigue, headache (What is headache?), vaginal infection on Aug 05, 2010 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 148.0 lb, was diagnosed with atrophic vulvovaginitis, vulvovaginal dryness and. Estrace dosage: 1 Gram 2 Nights In A Row.

6895966-4 | Oedema Peripheral, Supraventricular Tachycardia
Adverse event was reported on Jul 14, 2010 by a Female patient taking Estrace (View Usage) (Dosage: Single Dose, Vaginal) was diagnosed with vaginal infection and. Location: UNITED STATES , 74 years of age, weighting 145.1 lb, Patient experienced the following unwanted or unexpected effects: oedema peripheral, supraventricular tachycardia. During the same period patient was treated with TOPRIL (RAMIPRIL) (View Topril (ramipril) Review and Topril (ramipril) Label ), NORVASC (View Norvasc Review and Norvasc Label ), PRINIVIL (LISINOPRIL DIHYDRATE) (View Prinivil (lisinopril Dihydrate) Review and Prinivil (lisinopril Dihydrate) Label ).

6856892-X | Alopecia
on Jun 14, 2010 Female patient from UNITED STATES , 57 years of age, weighting 152.1 lb, was diagnosed with glaucoma (What is glaucoma?), cardiac failure congestive, blood pressure (What is blood pressure?), gastrooesophageal reflux disease and was treated with Estrace (View Usage). Patient had the following side effects: alopecia. Estrace dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), COSOPT (View Cosopt Review and Cosopt Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6856883-9 | Fungal Infection, Oedema Peripheral, Vaginal Swelling, Vulvovaginal Discomfort
on Feb 16, 2010 Female patient from UNITED STATES , 48 years of age, was diagnosed with vulvovaginal dryness and was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: fungal infection (What is fungal infection?), oedema peripheral, vaginal swelling, vulvovaginal discomfort. Estrace dosage: . During the same period patient was treated with FEMRING (Femring Vaginal Ring) (View Femring Review and Femring Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), BUSPAR (View Buspar Review and Buspar Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

6856881-5 | Breast Cancer In Situ
Patient was taking Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer in situ on Dec 01, 2009 from UNITED STATES Additional patient health information: Female patient , 73 years of age, weighting 191.8 lb, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?), hypercholesterolaemia and. Estrace dosage: . During the same period patient was treated with PROGESTERONE (View Progesterone Review and Progesterone Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LIBRAX (View Librax Review and Librax Label ), ASPIRIN (1df=1/2tablet) (View Aspirin Review and Aspirin Label ), ZOCOR (1/2 Qd) (View Zocor Review and Zocor Label ), LANOXIN (In 1997) (View Lanoxin Review and Lanoxin Label ).

6856879-7 | Breast Cancer
Adverse event was reported on Oct 22, 2009 by a Female patient taking Estrace (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 45 years of age, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with FLOVENT (View Flovent Review and Flovent Label ).

6856878-5 | Breast Cancer
on Oct 22, 2009 Female patient from UNITED STATES , 45 years of age, was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PROGESTERONE (View Progesterone Review and Progesterone Label ), FLOVENT (View Flovent Review and Flovent Label ).

6856877-3 | Breast Cancer
on Oct 22, 2009 Female patient from UNITED STATES , 48 years of age, was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Estrace dosage: 17 Beta Estradiol. During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), PREMPRO (1 Df = 1 Tab) (View Prempro Review and Prempro Label ). Patient was hospitalized.

6856875-X | Breast Cancer
Patient was taking Estrace (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Jul 16, 2009 from UNITED STATES Additional patient health information: Female patient , 75 years of age, . Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTROGEN (View Estrogen Review and Estrogen Label ), CYCRIN (View Cycrin Review and Cycrin Label ), AYGESTIN (View Aygestin Review and Aygestin Label ), PREMPRO (View Prempro Review and Prempro Label ), CENESTIN (View Cenestin Review and Cenestin Label ).

6856874-8 | Breast Cancer
Adverse event was reported on Nov 13, 2009 by a Female patient taking Estrace (View Usage) (Dosage: Initialy Taken From 1998-1999 And Again Taken From Jun02) was diagnosed with menopause (What is menopause?), hot flush, night sweats and. Location: UNITED STATES , 69 years of age, After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with CLIMARA (Initialy Taken From 1998-99 And Again From Jul02.) (View Climara Review and Climara Label ), PREMARIN (View Premarin Review and Premarin Label ).

6822632-3 | Breast Cancer In Situ, Oestrogen Receptor Assay Positive, Progesterone Receptor Assay Positive
on Jul 06, 2010 Female patient from UNITED STATES , 42 years of age, weighting 135.0 lb, was diagnosed with postoperative care, vaginal disorder, vaginal operation and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer in situ, oestrogen receptor assay positive, progesterone receptor assay positive. Estrace dosage: Small Amount In Vagina 2 Times A Week Vag.

6761171-5 | Anxiety, Aphasia, Back Pain, Cervicobrachial Syndrome, Chronic Sinusitis, Dizziness, Foreign Body, Joint Range Of Motion Decreased, Joint Swelling
on May 24, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with atrophic vulvovaginitis and was treated with Estrace (View Usage). Patient had the following side effects: anxiety (What is anxiety?), aphasia (What is aphasia?), back pain (What is back pain?), cervicobrachial syndrome, chronic sinusitis, dizziness (What is dizziness?), foreign body, joint range of motion decreased, joint swelling. Estrace dosage: Once Weekly, Vaginal. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CRESTOR (View Crestor Review and Crestor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6748157-1 | Breast Cancer
Patient was taking Estrace (View Usage). After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?) on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, was diagnosed with menopausal symptoms and. Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

6707629-6 | Atrioventricular Block, Cardiac Arrest, Cystitis, Head Injury, Loss Of Consciousness, Vaginitis Bacterial, Vulvovaginal Mycotic Infection
Adverse event was reported on Apr 20, 2010 by a Female patient taking Estrace (View Usage) (Dosage: 1 Gm, Monday, Wednesday, Friday, Vaginal) was diagnosed with vulvovaginal pain and. Location: UNITED STATES , 83 years of age, weighting 125.9 lb, Patient experienced the following unwanted or unexpected effects: atrioventricular block, cardiac arrest (What is cardiac arrest?), cystitis, head injury, loss of consciousness, vaginitis bacterial, vulvovaginal mycotic infection. During the same period patient was treated with CALCIUM (CALCIUM GLUBIONATE) (View Calcium (calcium Glubionate) Review and Calcium (calcium Glubionate) Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), COUMADIN (COUMARIN) (View Coumadin (coumarin) Review and Coumadin (coumarin) Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6694256-2 | Back Pain, Foreign Body, Pelvic Mass, Transient Ischaemic Attack
on Apr 12, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with atrophic vulvovaginitis and was treated with Estrace (View Usage). Patient had the following side effects: back pain (What is back pain?), foreign body, pelvic mass, transient ischaemic attack. Estrace dosage: Once Weekly, Vaginal. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CRESTOR (View Crestor Review and Crestor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6686258-7 | Complication Of Device Insertion, Concussion, Fibromyalgia, Vulvovaginal Pain
on Apr 08, 2010 Female patient from UNITED STATES , 55 years of age, weighting 149.9 lb, was diagnosed with vulvovaginal dryness, vulvovaginal pain and was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: complication of device insertion, concussion (What is concussion?), fibromyalgia, vulvovaginal pain. Estrace dosage: 3-4 Times Weekly, Vaginal. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

6680333-9 | Balance Disorder, Cerebral Disorder, Complication Of Device Insertion, Concussion, Fatigue, Fibromyalgia, Infectious Mononucleosis, Lyme Disease, Pain
Patient was taking Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: balance disorder, cerebral disorder, complication of device insertion, concussion (What is concussion?), fatigue, fibromyalgia, infectious mononucleosis (What is infectious mononucleosis?), lyme disease, pain (What is pain?) on Apr 07, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 149.9 lb, was diagnosed with dyspareunia, vulvovaginal dryness and. Estrace dosage: 3-4 Times Weekly, Vaginal. During the same period patient was treated with ZOLOFT (View Zoloft Review and Zoloft Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ).

6679934-3 | Arthralgia, Malaise, Nausea, Proteus Infection, Urinary Tract Infection Pseudomonal
Adverse event was reported on Apr 01, 2010 by a Female patient taking Estrace (View Usage) (Dosage: Vaginal) was diagnosed with vaginal disorder and. Location: UNITED STATES , 86 years of age, weighting 159.0 lb, Patient had the following side effects: arthralgia, malaise, nausea (What is nausea?), proteus infection, urinary tract infection pseudomonal. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), COUMADIN (View Coumadin Review and Coumadin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NORVASC (View Norvasc Review and Norvasc Label ), PREVACID (View Prevacid Review and Prevacid Label ), PEPCID (CALCIUM CARBONATE, POTASSIUM CHLORIDE) (View Pepcid (calcium Carbonate, Potassium Chloride) Review and Pepcid (calcium Carbonate, Potassium Chloride) Label ), POTASSIUM (POTASSIUM BICARBONATE, POTASSIUM CHLORIDE) (View Potassium (potassium Bicarbonate, Potassium Chloride) Review and Potassium (potassium Bicarbonate, Potassium Chloride) Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

6618764-5 | Application Site Burn, Breast Tenderness, Sensory Loss, Vulvovaginal Disorder
on Mar 05, 2010 Female patient from UNITED STATES , weighting 135.4 lb, was diagnosed with soft tissue disorder and was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: application site burn, breast tenderness, sensory loss, vulvovaginal disorder. Estrace dosage: 1gm Into Vagina 3 Times Per Week 066. During the same period patient was treated with CALCIUM/VIT D (View Calcium/vit D Review and Calcium/vit D Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), ZOCOR (View Zocor Review and Zocor Label ), ZESTRIL (View Zestril Review and Zestril Label ), JANUVIA (View Januvia Review and Januvia Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

6566904-9 | Amnesia, Hypertensive Crisis, Transient Ischaemic Attack
on Jan 18, 2010 Female patient from UNITED STATES , 66 years of age, weighting 123.9 lb, was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, hypertensive crisis, transient ischaemic attack. Estrace dosage: 1 Gram Two Times Weekly, Vaginal. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ).

6461519-5 | Convulsion
Patient was taking Estrace (View Usage). Patient had the following side effects: convulsion on Nov 11, 2009 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 119.9 lb, . Estrace dosage: 1/4 Applicator, Qod For 1-2 Doses, Then Q3rd Day, Vaginal. During the same period patient was treated with PROTONIX (View Protonix Review and Protonix Label ).

6442937-8 | Blood Pressure Systolic Increased, Dizziness, Fatigue, Headache, Hypertension, Loss Of Consciousness, Speech Disorder, Transient Ischaemic Attack
Adverse event was reported on Nov 06, 2009 by a Female patient taking Estrace (View Usage) (Dosage: Qd, Outer Vaginal, Topical) was diagnosed with menopause (What is menopause?), vulvovaginal dryness and. Location: UNITED STATES , 52 years of age, weighting 119.9 lb, After Estrace was administered, patient had the following side effects: blood pressure systolic increased, dizziness (What is dizziness?), fatigue, headache (What is headache?), hypertension, loss of consciousness, speech disorder, transient ischaemic attack. During the same period patient was treated with VITAMINE E (TOCOPHERY ACETATE) (View Vitamine E (tocophery Acetate) Review and Vitamine E (tocophery Acetate) Label ). Patient was hospitalized.

6436770-0 | Dizziness, Headache, Hypertension, Loss Of Consciousness, Speech Disorder, Transient Ischaemic Attack
on Oct 27, 2009 Female patient from UNITED STATES , 52 years of age, weighting 119.9 lb, was diagnosed with vulvovaginal dryness, menopause (What is menopause?) and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), headache (What is headache?), hypertension, loss of consciousness, speech disorder, transient ischaemic attack. Estrace dosage: Qd, Outer Vaginal, Topical. During the same period patient was treated with VIVELLE DOT (Transdermal) (View Vivelle-dot Review and Vivelle-dot Label ), VITAMIN E (TOCOPHERYL ACETATE) (View Vitamin E (tocopheryl Acetate) Review and Vitamin E (tocopheryl Acetate) Label ). Patient was hospitalized.

6409379-2 | Abdominal Pain, Impaired Gastric Emptying, Nausea
on Oct 19, 2009 Female patient from UNITED STATES , 53 years of age, weighting 213.4 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Estrace (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), impaired gastric emptying, nausea (What is nausea?). Estrace dosage: 2 Mg 5 Tablets (10mg) Tid. During the same period patient was treated with LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), COUMADIN (View Coumadin Review and Coumadin Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), PREVACID (View Prevacid Review and Prevacid Label ), CALCIUM GLUCONATE (View Calcium Gluconate Review and Calcium Gluconate Label ). Patient was hospitalized.

6314136-1 | Blister, Confusional State, Dermatitis Allergic, Dysuria, Erythema Multiforme, Eye Burns, Pyrexia, Scar, Vulvovaginal Burning Sensation
Patient was taking Estrace (View Usage). After Estrace was administered, patient had the following side effects: blister, confusional state, dermatitis allergic, dysuria, erythema multiforme, eye burns, pyrexia, scar (What is scar?), vulvovaginal burning sensation on Aug 06, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, weighting 153.0 lb, was diagnosed with atrophic vulvovaginitis and. Estrace dosage: Qd, Topical. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ABILIFY (View Abilify Review and Abilify Label ), DOCUSATE SODIUM (DOCUSATE SODIUM) (View Docusate Sodium (docusate Sodium) Review and Docusate Sodium (docusate Sodium) Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), GLYCOLAX (MACROGOL) (View Glycolax (macrogol) Review and Glycolax (macrogol) Label ), HYOSCYAMINE (HYOSCYAMINE) (View Hyoscyamine (hyoscyamine) Review and Hyoscyamine (hyoscyamine) Label ). Patient was hospitalized.

6312000-5 | Uterine Leiomyoma
Adverse event was reported on Mar 24, 2009 by a Female patient taking Estrace (View Usage) (Dosage: Reduced To 1mg In 1991;increased To 1.5mg In 1996) . Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: uterine leiomyoma. During the same period patient was treated with PROVERA (Reduced To 2.5mg In 1996) (View Provera Review and Provera Label ).

6311999-0 | Breast Cancer
on Mar 20, 2009 Female patient from UNITED STATES , 75 years of age, was treated with Estrace (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), ESTROGEN (View Estrogen Review and Estrogen Label ), CYCRIN (View Cycrin Review and Cycrin Label ), AYGESTIN (View Aygestin Review and Aygestin Label ), PREMPRO (View Prempro Review and Prempro Label ), CENESTIN (View Cenestin Review and Cenestin Label ).

6311993-X | Breast Cancer
on Oct 24, 2008 Female patient from UNITED STATES , 56 years of age, was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), PREMPHASE 14/14 (View Premphase 14/14 Review and Premphase 14/14 Label ), ESTRATEST (View Estratest Review and Estratest Label ), OGEN (View Ogen Review and Ogen Label ), CYCRIN (View Cycrin Review and Cycrin Label ), ESTRADERM (View Estraderm Review and Estraderm Label ).

6311961-8 | Breast Cancer
Patient was taking Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on May 14, 2009 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 174.2 lb, . Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NORVASC (View Norvasc Review and Norvasc Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM (View Calcium Review and Calcium Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ).

6311954-0 | Breast Cancer
Adverse event was reported on May 18, 2009 by a Female patient taking Estrace (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), FEMHRT (View Femhrt Review and Femhrt Label ).

6311935-7 | Breast Cancer
on May 14, 2009 Female patient from UNITED STATES , 50 years of age, weighting 235.9 lb, was diagnosed with pain (What is pain?), tinnitus (What is tinnitus?) and was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PROVERA (View Provera Review and Provera Label ), PREMPRO (View Prempro Review and Prempro Label ), CLARITIN D (View Claritin-d Review and Claritin-d Label ), BECONASE (1 Df=two Squirts In Each Nostril Once A Day To Twice A Day) (View Beconase Review and Beconase Label ), ADVIL (View Advil Review and Advil Label ), NABUMETONE (View Nabumetone Review and Nabumetone Label ).

6311925-4 | Breast Cancer
on Aug 19, 2008 Female patient from UNITED STATES , 69 years of age, was diagnosed with menopause (What is menopause?), hot flush, night sweats and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Estrace dosage: Initialy Taken From 1998-1999 And Again Taken From Jun02. During the same period patient was treated with CLIMARA (Initialy Taken From 1998-99 And Again From Jul02.) (View Climara Review and Climara Label ), PREMARIN (View Premarin Review and Premarin Label ).

6303526-9 | Alopecia, Cognitive Disorder, Dizziness, Dyspepsia, Dyspnoea, Fatigue, Flatulence, Muscle Spasms, Thirst
Patient was taking Estrace (View Usage). Patient had the following side effects: alopecia, cognitive disorder, dizziness (What is dizziness?), dyspepsia, dyspnoea, fatigue, flatulence, muscle spasms, thirst on Aug 07, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with mucosal dryness and. Estrace dosage: 2 Gms Vag Chs X2 Wks Then 1gm Q 2wks Vaginal. During the same period patient was treated with SYTHROID (View Sythroid Review and Sythroid Label ).

6295543-2 | Blister, Confusional State, Pyrexia, Rash, Scar, Vulvovaginal Burning Sensation, Vulvovaginal Pain, Vulvovaginal Pruritus
Adverse event was reported on Jul 22, 2009 by a Female patient taking Estrace (View Usage) (Dosage: Qd, Topical) was diagnosed with atrophic vulvovaginitis and. Location: UNITED STATES , 58 years of age, weighting 153.0 lb, After Estrace was administered, patient had the following side effects: blister, confusional state, pyrexia, rash (What is rash?), scar (What is scar?), vulvovaginal burning sensation, vulvovaginal pain, vulvovaginal pruritus. During the same period patient was treated with WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ABILIFY (View Abilify Review and Abilify Label ). Patient was hospitalized.

6201861-6 | Application Site Discharge, Myofascial Pain Syndrome, Product Quality Issue
on May 08, 2009 Female patient from UNITED STATES , 79 years of age, weighting 145.1 lb, was diagnosed with urethral syndrome and was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: application site discharge, myofascial pain syndrome, product quality issue. Estrace dosage: Vaginal. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CORGARD (View Corgard Review and Corgard Label ), NORTRIPTYLINE HCL (View Nortriptyline Hcl Review and Nortriptyline Hcl Label ), BUSPAR (View Buspar Review and Buspar Label ), ULTRAM (View Ultram Review and Ultram Label ), ADVIL (View Advil Review and Advil Label ), NEXIUM (View Nexium Review and Nexium Label ).

6201796-9 | Bladder Prolapse, Underdose, Uterine Prolapse
on May 06, 2009 Female patient from UNITED STATES , 70 years of age, weighting 134.9 lb, was diagnosed with vulvovaginal dryness and was treated with Estrace (View Usage). Patient had the following side effects: bladder prolapse, underdose, uterine prolapse. Estrace dosage: Dose, 1x A Month, Vaginal; 2 X A Month.

6199652-8 | Migraine With Aura, Optic Ischaemic Neuropathy, Retinal Artery Occlusion
Patient was taking Estrace (View Usage). After Estrace was administered, patient had the following side effects: migraine with aura, optic ischaemic neuropathy, retinal artery occlusion on May 20, 2009 from UNITED STATES Additional patient health information: Female patient , 56 years of age, weighting 106.0 lb, was diagnosed with vulvovaginal dryness and. Estrace dosage: 2 Grams 2 X Wkly Vaginally. During the same period patient was treated with VAGIFEM VAGINAL TABLETS (View Vagifem Vaginal Tablets Review and Vagifem Vaginal Tablets Label ).

6195736-9 | Breast Cancer
Adverse event was reported on May 18, 2009 by a Female patient taking Estrace (View Usage) (Dosage: ) was diagnosed with menopausal symptoms and. Location: UNITED STATES , 72 years of age, weighting 174.2 lb, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ).

6195376-1 | Breast Cancer
on May 18, 2009 Female patient from UNITED STATES , 59 years of age, weighting 231.5 lb, was diagnosed with menopausal symptoms and was treated with Estrace (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), ESTRATEST (View Estratest Review and Estratest Label ), CENESTIN (View Cenestin Review and Cenestin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ZOLOFT (Also Taken 200mg/daily.) (View Zoloft Review and Zoloft Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6195336-0 | Breast Cancer
on May 18, 2009 Female patient from UNITED STATES , 53 years of age, weighting 141.1 lb, was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PROVERA (Day 1-15) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), FEMHRT (View Femhrt Review and Femhrt Label ), PREMARIN (View Premarin Review and Premarin Label ).

6192106-4 | Breast Cancer
Patient was taking Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?) on May 14, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, weighting 105.8 lb, was diagnosed with menopause (What is menopause?) and. Estrace dosage: . During the same period patient was treated with ESTRATAB (View Estratab Review and Estratab Label ), OGEN (View Ogen Review and Ogen Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ).

6165110-X | Breast Cancer
Adverse event was reported on Apr 21, 2009 by a Female patient taking Estrace (View Usage) (Dosage: ) . Location: UNITED STATES , 55 years of age, weighting 138.9 lb, Patient had the following side effects: breast cancer (What is breast cancer?). During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ).

6158903-6 | Crying, Influenza, Neck Pain, Throat Tightness, Thyroid Cyst, Weight Decreased
on Apr 02, 2009 Female patient from UNITED STATES , 46 years of age, weighting 160.9 lb, was diagnosed with vulvovaginal dryness and was treated with Estrace (View Usage). After Estrace was administered, patient had the following side effects: crying, influenza, neck pain, throat tightness, thyroid cyst, weight decreased. Estrace dosage: 1 G, Tid, Vaginal. During the same period patient was treated with CELEXA /00582602/ (CITALOPRAM HYDROBROMIDE) (View Celexa /00582602/ (citalopram Hydrobromide) Review and Celexa /00582602/ (citalopram Hydrobromide) Label ).

6136304-4 | Breast Cancer
on Mar 26, 2009 Female patient from UNITED STATES , 44 years of age, was treated with Estrace (View Usage). Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). Estrace dosage: . During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTROGENIC SUBSTANCE (View Estrogenic Substance Review and Estrogenic Substance Label ).

6136299-3 | Breast Cancer
Patient was taking Estrace (View Usage). Patient had the following side effects: breast cancer (What is breast cancer?) on Mar 26, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 152.1 lb, was diagnosed with menopausal symptoms and. Estrace dosage: . During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), PROVERA (View Provera Review and Provera Label ), MEDROXYPROGESTERONE ACETATE (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).